Cell-containing substrates and vaccine production
Majer, M.
Schweizerische Medizinische Wochenschrift 100(48): 2086-2089
1970
ISSN/ISBN: 0036-7672 PMID: 5003834 Document Number: 19676
Document emailed within 1 workday
Related Documents
Glathe, H.; Abel, C. 1977: Evidence of tumorigenic activity of candidate cell substrates in vaccine production by use of antilymphocyte serum Developments in Biological Standardization 34: 145-148Grachev, V.; Magrath, D. 1989: Status of WHO concerning continuous cell lines as substrates for the production of biologicals Developments in Biological Standardization 70: 215-219
Dull, H.B. 1979: Cell substrates. their use in the production of vaccines and other biologicals. Benefit-risk assessment Advances in Experimental Medicine and Biology 118: 187-193
Hayflick, L. 1970: The choice of the cell substrate for human virus vaccine production Laboratory Practice 19(1): 58-62
Karmysheva, V.I.; Rovenskiĭ, I.A.; Mironova, O.I.; Koniushko, O.I.; Khapchaev, I.K. 1992: The morphology of cell lines suitable for vaccine production studied by scanning electron microscopy Tsitologiia 34(1): 84-88
Rau, C.; Voiculescu, C.; Palade, V. 1976: The significance of positive controls in testing the oncogenic potential of cell material for virus vaccine production Developments in Biological Standardization 37: 241-244
Smith, K.O. 1970: Use of cell cultures in vaccine production: primary cell cultures Journal of the American Veterinary Medical Association 156(12): 1787-1790
Arai, Y.T.; Montalban, C.S. 1993: Comparative studies on chick embryo cell rabies vaccine and human diploid cell vaccine: pre-exposure use and purity of the vaccines Southeast Asian Journal of Tropical Medicine and Public Health 24(4): 747-750
LaForce, F.M. 2011: Technology transfer to developing country vaccine manufacturers to improve global influenza vaccine production: a success story and a window into the future Vaccine 29(Suppl 1): A1
Sánchez-Marroquín, A. 1971: Sugar cane and agave juices as substrates for the microbiological production of SCP, L-lysine and riboflavin Revista Latinoamericana de Microbiologia 13(2): 107-112
Kurhaliuk, N.M.; Kotsiuruba, A.V.; Sahach, V.F. 2005: The modification of nitric oxide production by exogenous substrates of Krebs cycle during acute hypoxia Fiziolohichnyi Zhurnal 51(4): 20-28
Nakada, S. 1987: New technology of vaccine production--international prospect of the development--subunit vaccine obtained by genetic engineering. b. Genetic engineering method using animal cells Nihon Rinsho. Japanese Journal of Clinical Medicine 45(10): 2326-2332
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Lubiniecki, A.S.; Dinowitz, M.; Nelson, E.; Wiebe, M.; May, L.; Ogez, J.; Builder, S. 1989: Endogenous retroviruses of continuous cell substrates Developments in Biological Standardization 70: 187-191
Petricciani, J. 2010: Animal cell substrates: back to the future PDA Journal of Pharmaceutical Science and Technology 64(5): 375-378
Kalter, S.S.; Heberling, R.L.; Helmke, R.J.; Abernathy, D.R. 1976: Establishment of cell substrates for nonhuman primates Developments in Biological Standardization 37: 27-33
Khan, A.S. 2010: Testing considerations for novel cell substrates: a regulatory perspective PDA Journal of Pharmaceutical Science and Technology 64(5): 426-431
Biggs, P.M. 1970: Production of pathogen free avian cell substrate for production of vaccines Laboratory Practice 19(1): 45-49
Kado, G. 1976: Relative sensitivity of three cell substrates to the Sabin poliovirus strains Developments in Biological Standardization 37: 261-264
Sakata, K.; Tashiro, K.; Hirashima, M.; Hayashi, H. 1985: Selective regulation of chemotactic lymphokine production. I. Selective potentiation of eosinophil chemotactic lymphokine production in alum hydroxy gel- and Bordetella pertussis vaccine-treated guinea pigs Journal of Immunology 135(5): 3463-3467